ME00876B - 4"supstituisani-9-deokso-9a-aza-9a-homoeritromicin a derivati - Google Patents

4"supstituisani-9-deokso-9a-aza-9a-homoeritromicin a derivati

Info

Publication number
ME00876B
ME00876B MEP-1999-586A MEP1999586A ME00876B ME 00876 B ME00876 B ME 00876B ME P1999586 A MEP1999586 A ME P1999586A ME 00876 B ME00876 B ME 00876B
Authority
ME
Montenegro
Prior art keywords
homoerythromycin
deoxo
aza
derivatives
substituted
Prior art date
Application number
MEP-1999-586A
Other languages
English (en)
Unknown language (me)
Inventor
Brian Scott Bronk
Michael A Letavic
Takushi Kaneko
Bingwei Vera Yang
Edward Alan Glazer
Hengmiao Cheng
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21959336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00876(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of ME00876B publication Critical patent/ME00876B/me

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MEP-1999-586A 1997-06-11 1998-05-29 4"supstituisani-9-deokso-9a-aza-9a-homoeritromicin a derivati ME00876B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4934897P 1997-06-11 1997-06-11
PCT/IB1998/000839 WO1998056802A1 (en) 1997-06-11 1998-05-29 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives

Publications (1)

Publication Number Publication Date
ME00876B true ME00876B (me) 2012-06-20

Family

ID=21959336

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-1999-586A ME00876B (me) 1997-06-11 1998-05-29 4"supstituisani-9-deokso-9a-aza-9a-homoeritromicin a derivati

Country Status (50)

Country Link
US (4) US6420536B1 (US06559137-20030506-C00182.png)
EP (1) EP0988310B9 (US06559137-20030506-C00182.png)
JP (2) JP3315704B2 (US06559137-20030506-C00182.png)
KR (1) KR100396168B1 (US06559137-20030506-C00182.png)
CN (4) CN101691390A (US06559137-20030506-C00182.png)
AP (1) AP1231A (US06559137-20030506-C00182.png)
AR (1) AR013086A1 (US06559137-20030506-C00182.png)
AT (1) ATE251173T1 (US06559137-20030506-C00182.png)
AU (1) AU749816B2 (US06559137-20030506-C00182.png)
BG (1) BG64391B1 (US06559137-20030506-C00182.png)
BR (1) BRPI9810519B8 (US06559137-20030506-C00182.png)
CA (1) CA2293823C (US06559137-20030506-C00182.png)
CO (1) CO4950611A1 (US06559137-20030506-C00182.png)
CZ (1) CZ298556B6 (US06559137-20030506-C00182.png)
DE (2) DE122004000018I2 (US06559137-20030506-C00182.png)
DK (1) DK0988310T3 (US06559137-20030506-C00182.png)
DZ (1) DZ2514A1 (US06559137-20030506-C00182.png)
EA (1) EA002441B1 (US06559137-20030506-C00182.png)
EG (1) EG24081A (US06559137-20030506-C00182.png)
ES (1) ES2205487T3 (US06559137-20030506-C00182.png)
FR (1) FR04C0013I2 (US06559137-20030506-C00182.png)
GT (1) GT199800077A (US06559137-20030506-C00182.png)
HK (3) HK1028048A1 (US06559137-20030506-C00182.png)
HN (1) HN1998000086A (US06559137-20030506-C00182.png)
HR (1) HRP980314B1 (US06559137-20030506-C00182.png)
HU (2) HU228005B1 (US06559137-20030506-C00182.png)
ID (1) ID22992A (US06559137-20030506-C00182.png)
IL (1) IL132809A0 (US06559137-20030506-C00182.png)
IS (1) IS1998B (US06559137-20030506-C00182.png)
LU (1) LU91076I9 (US06559137-20030506-C00182.png)
MA (1) MA24564A1 (US06559137-20030506-C00182.png)
ME (1) ME00876B (US06559137-20030506-C00182.png)
MY (1) MY123354A (US06559137-20030506-C00182.png)
NL (1) NL300150I2 (US06559137-20030506-C00182.png)
NO (1) NO316911B1 (US06559137-20030506-C00182.png)
NZ (2) NZ500660A (US06559137-20030506-C00182.png)
OA (1) OA11224A (US06559137-20030506-C00182.png)
PA (1) PA8452201A1 (US06559137-20030506-C00182.png)
PE (1) PE79699A1 (US06559137-20030506-C00182.png)
PL (1) PL191601B1 (US06559137-20030506-C00182.png)
PT (1) PT988310E (US06559137-20030506-C00182.png)
RS (1) RS49675B (US06559137-20030506-C00182.png)
SI (1) SI0988310T1 (US06559137-20030506-C00182.png)
SK (1) SK284171B6 (US06559137-20030506-C00182.png)
TN (1) TNSN98082A1 (US06559137-20030506-C00182.png)
TW (1) TW472060B (US06559137-20030506-C00182.png)
UA (1) UA67744C2 (US06559137-20030506-C00182.png)
UY (1) UY25040A1 (US06559137-20030506-C00182.png)
WO (1) WO1998056802A1 (US06559137-20030506-C00182.png)
ZA (1) ZA985017B (US06559137-20030506-C00182.png)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
WO1999012552A1 (en) * 1997-09-10 1999-03-18 Merck & Co., Inc. 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
EP1779853A3 (en) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides as veterinary antimicrobial agents
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
CA2411293A1 (en) * 1999-01-28 2000-07-28 Pfizer Products Inc. Novel azalides and methods of making same
DK1189912T3 (da) * 1999-05-18 2008-06-30 Pfizer Prod Inc Nye krystallinske former af et makrolid antibiotikum
SK15162001A3 (sk) * 1999-05-24 2003-02-04 Pfizer Products Inc. Deriváty 13-metylerytromycínu
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
DE60025370T2 (de) * 1999-08-24 2006-09-21 Abbott Laboratories, Abbott Park 9a-azalide mit antibakterieller wirkung
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
US6608033B1 (en) 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
PT1250343E (pt) * 2000-01-27 2003-11-28 Pfizer Prod Inc Composicoes de antibioticos de azalida
KR20030031479A (ko) * 2000-04-27 2003-04-21 화이자 프로덕츠 인코포레이티드 포유동물에서 세균 감염 또는 원생생물 감염을 치료 또는 예방하기 위한 아잘라이드 항생제 조성물
BR0209241A (pt) * 2001-04-27 2004-06-15 Pfizer Prod Inc Processo para preparação de derivados de9-deoxo-9a-aza-9a-homoeritromicina a 4-substituida
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
CA2529817C (en) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
CA2546195A1 (en) * 2003-11-21 2005-06-02 Pfizer Products Inc. The use of anti biotics as vaccine adjuvants
NZ550464A (en) * 2004-03-16 2010-10-29 Boehringer Ingelheim Int Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7402568B2 (en) 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
US7767797B1 (en) * 2004-09-30 2010-08-03 Synovo Gmbh Macrocyclic compounds and methods of use thereof
US7271155B2 (en) 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
US20080227730A1 (en) * 2005-01-14 2008-09-18 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. 9A-Carbamoyl and Thiocarbamoyl Azalides With Antimalarial Activity
JP5698979B2 (ja) * 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ,インコーポレイテッド マクロライド系抗菌剤の調製プロセス
JP5602748B2 (ja) 2008-10-24 2014-10-08 センプラ ファーマシューティカルズ,インコーポレイテッド トリアゾール含有マクロライドを用いた生体防御
US9937194B1 (en) * 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
DK2550286T3 (en) 2010-03-22 2016-02-29 Cempra Pharmaceuticals Inc CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ,インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
ES2532455T3 (es) 2010-09-20 2015-03-27 Novartis Tiergesundheit Ag Nuevo procedimiento de preparación de 9-desoxo-9a-aza-9a-homoeritromicina modificada en el C-4'' del anillo de cladinosa por un grupo epóxido
CA2814333A1 (en) * 2010-10-10 2012-04-19 Synovo Gmbh Anti-inflammatory macrolides
CN102993250B (zh) * 2011-07-06 2016-02-10 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
WO2013013834A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
US10188674B2 (en) 2012-03-27 2019-01-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
CN102786569B (zh) * 2012-09-07 2016-12-07 安徽中升药业有限公司 泰拉霉素中间体及其制备方法与泰拉霉素的制备方法
JP6426696B2 (ja) 2013-03-14 2018-11-21 センプラ ファーマシューティカルズ,インコーポレイテッド 呼吸器疾患の治療のための方法および製剤
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
SI3027634T1 (sl) * 2013-07-31 2018-10-30 Farma Grs, D.O.O. Proces za pripravo tulatromicina
CN103497227B (zh) * 2013-09-13 2015-09-30 青岛科技大学 一种泰拉菌素中间体的制备方法
CN104725446B (zh) * 2015-03-26 2017-10-27 宁夏泰瑞制药股份有限公司 一种从泰拉霉素粗品中分离泰拉霉素a和泰拉霉素b的方法
CN104861018A (zh) * 2015-06-17 2015-08-26 瑞普(天津)生物药业有限公司 一种泰拉菌素的制备方法
CN105646617A (zh) * 2016-01-21 2016-06-08 杭州海尔希畜牧科技有限公司 一种制备泰拉霉素的方法
FR3048612B1 (fr) * 2016-03-14 2020-10-02 Septeos Tulathromycine potentialisee
CN106046077B (zh) * 2016-08-04 2019-07-26 湖北美天生物科技股份有限公司 一种泰拉霉素a的合成方法
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法
CN111087433B (zh) * 2018-10-23 2023-03-21 湖北美天生物科技股份有限公司 一种泰拉霉素中间体的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5226958A (en) * 1991-04-11 1993-07-13 Pacemark, Inc. Sealant for pneumatic inner tubes and tubeless tires
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
KR20010013632A (ko) 2001-02-26
DK0988310T3 (da) 2003-12-15
LU91076I9 (en) 2018-07-02
HRP980314A2 (en) 1999-04-30
DE122004000018I1 (de) 2004-09-30
NZ514871A (en) 2003-08-29
HK1028048A1 (en) 2001-02-02
EP0988310B1 (en) 2003-10-01
PA8452201A1 (es) 2000-05-24
ZA985017B (en) 1999-12-17
ATE251173T1 (de) 2003-10-15
HUS1200028I1 (hu) 2016-08-29
US20040023896A1 (en) 2004-02-05
US20040180842A1 (en) 2004-09-16
PL337505A1 (en) 2000-08-28
SK168399A3 (en) 2000-11-07
UA67744C2 (uk) 2004-07-15
CA2293823A1 (en) 1998-12-17
NO996106D0 (no) 1999-12-10
EA199901015A1 (ru) 2000-06-26
YU58699A (US06559137-20030506-C00182.png) 2002-08-12
BRPI9810519B1 (pt) 2012-02-22
GT199800077A (es) 1999-12-02
AU7347598A (en) 1998-12-30
ID22992A (id) 1999-12-23
US6777393B2 (en) 2004-08-17
EP0988310B9 (en) 2006-03-08
BRPI9810519A (pt) 2000-09-19
IL132809A0 (en) 2001-03-19
DE69818665D1 (de) 2003-11-06
OA11224A (en) 2003-07-16
FR04C0013I1 (US06559137-20030506-C00182.png) 2004-06-11
AU749816B2 (en) 2002-07-04
JP2000514098A (ja) 2000-10-24
US6936592B2 (en) 2005-08-30
CN101691390A (zh) 2010-04-07
CN1243766C (zh) 2006-03-01
CN1172947C (zh) 2004-10-27
BG103945A (en) 2000-07-31
HUP0002209A2 (hu) 2000-12-28
JP3315704B2 (ja) 2002-08-19
CA2293823C (en) 2004-02-17
LU91076I2 (fr) 2004-07-05
HN1998000086A (es) 1999-03-08
HK1088014A1 (en) 2006-10-27
TNSN98082A1 (fr) 2005-03-15
KR100396168B1 (ko) 2003-08-27
SI0988310T1 (en) 2004-02-29
DE69818665T2 (de) 2004-04-29
CN1566129A (zh) 2005-01-19
PT988310E (pt) 2003-12-31
NO316911B1 (no) 2004-06-21
CZ298556B6 (cs) 2007-11-07
AP9801255A0 (en) 1998-06-30
DZ2514A1 (fr) 2003-02-01
HRP980314B1 (en) 2004-04-30
BG64391B1 (bg) 2004-12-30
EA002441B1 (ru) 2002-04-25
RS49675B (sr) 2007-11-15
IS5252A (is) 1999-11-16
AR013086A1 (es) 2000-12-13
US6420536B1 (en) 2002-07-16
CN1259136A (zh) 2000-07-05
AP1231A (en) 2003-12-11
TW472060B (en) 2002-01-11
CO4950611A1 (es) 2000-09-01
UY25040A1 (es) 2000-09-29
US20020061858A1 (en) 2002-05-23
HUP0002209A3 (en) 2003-05-28
IS1998B (is) 2005-03-15
JP2002316933A (ja) 2002-10-31
DE122004000018I2 (de) 2011-01-13
NL300150I1 (nl) 2004-08-02
CN1793155B (zh) 2010-05-12
MY123354A (en) 2006-05-31
WO1998056802A1 (en) 1998-12-17
BRPI9810519B8 (pt) 2022-11-16
EP0988310A1 (en) 2000-03-29
SK284171B6 (sk) 2004-10-05
PE79699A1 (es) 1999-08-25
MA24564A1 (fr) 1998-12-31
CN1793155A (zh) 2006-06-28
HU228005B1 (en) 2012-08-28
EG24081A (en) 2008-05-11
NO996106L (no) 2000-02-10
FR04C0013I2 (US06559137-20030506-C00182.png) 2005-10-21
NZ500660A (en) 2002-03-01
CZ442199A3 (cs) 2000-07-12
ES2205487T3 (es) 2004-05-01
NL300150I2 (nl) 2004-09-01
HK1068893A1 (en) 2005-07-29
PL191601B1 (pl) 2006-06-30

Similar Documents

Publication Publication Date Title
HK1088014A1 (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromy a derivatives
PL338429A1 (en) 2-[pyrazoyl-and triazolyl-3' -oksymethylene] phenylisoxazolones, -triazolones and -tetrazolones
ZA984478B (en) 5'-deoxy-cytidine derivatives
AU136766S (en) A bag
EP1046648A4 (en) 3'-DESOXYRIBONUCLEOTIDE DERIVATIVES
GB2330773B (en) A skin-moisturising preparation
GB2331915B (en) A mit
GB2336767B (en) A bag
GB9723845D0 (en) 6568471001
GB9703647D0 (en) A bag
GB9717959D0 (en) A holdall
AU133580S (en) A man's brief
AU133616S (en) A man's brief
AU133234S (en) A teapot-container
IL120253A0 (en) A screw - wrench
AU132788S (en) A pareo
AU132787S (en) A pareo
AU135496S (en) A crumpet
GB9712190D0 (en) A book-end
GB9715367D0 (en) A dredgehead
GB9707090D0 (en) Let'see
GB9723437D0 (en) Farysoft 2000
GB9722157D0 (en) Bastlock 2000
GB9724541D0 (en) 'NOBO'joiner
GB9708536D0 (en) A bag